Compare $ACXP vs $FBLG | Chartloom

Compare

$ACXP vs $FBLG

Acurx Pharmaceuticals Inc · Fibrobiologics Inc

ACXP

Acurx Pharmaceuticals Inc

FBLG

Fibrobiologics Inc

Compare $ACXP vs $FBLG

Comparing Acurx Pharmaceuticals Inc and Fibrobiologics Inc

ACXPAcurx Pharmaceuticals Inc

FBLGFibrobiologics Inc

ACXPAcurx Pharmaceuticals Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-54.0%

52W performance

-84.3%

FCF yield

-113.2%

FBLGFibrobiologics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.4%

52W performance

-88.8%

FCF yield

-215.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACXP

FBLG

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

FBLG

Fibrobiologics Inc

Market Cap

ACXP$5M

FBLG$7M

Enterprise Value

ACXP$-5M

FBLG$3M

Price

ACXP$1.27

FBLG$1.13

P/E Ratio

ACXPN/A

FBLGN/A

P/S Ratio

ACXP0.00x

FBLG0.00x

EV/Sales

ACXP0.00x

FBLG0.00x

EV/EBITDA

ACXP0.00x

FBLG0.00x

P/B Ratio

ACXP0.87x

FBLG1.78x

P/FCF Ratio

ACXPN/A

FBLGN/A

EV/FCF

ACXP0.84x

FBLG-0.24x

PEG Ratio

ACXPN/A

FBLGN/A

Forward P/E (NTM)

ACXPN/A

FBLGN/A

Forward P/S (NTM)

ACXPN/A

FBLGN/A

Revenue (TTM)

ACXP$0

FBLG$0

Revenue Growth (YoY)

ACXPN/A

FBLGN/A

Forward Rev Growth

ACXP40.7%

FBLG227.6%

Gross Margin (TTM)

ACXP0.0%

FBLG0.0%

Operating Margin (TTM)

ACXP0.0%

FBLG0.0%

EBITDA Margin (TTM)

ACXP0.0%

FBLG0.0%

Net Margin (TTM)

ACXP0.0%

FBLG0.0%

FCF Margin (TTM)

ACXPN/A

FBLGN/A

Net Income (TTM)

ACXP$-8M

FBLG$-18M

FCF (TTM)

ACXP$-6M

FBLG$-15M

EPS (TTM)

ACXP-$1.76

FBLG-$2.89

ROE (TTM)

ACXP-12474.0%

FBLG-53678.0%

ROA (TTM)

ACXP-8749.0%

FBLG-22512.0%

ROIC (TTM)

ACXP-12474.0%

FBLG-39304.0%

Cash

ACXP$11M

FBLG$4M

Debt

ACXP$0

FBLG$124K

Net Cash/Debt

ACXP$11M

FBLG$3M

Current Ratio (TTM)

ACXP3.88x

FBLG2.64x

Quick Ratio (TTM)

ACXP3.80x

FBLG2.40x

Debt/Equity (TTM)

ACXP0.00x

FBLG0.03x

Debt/Assets (TTM)

ACXP0.0%

FBLG0.0%

Interest Coverage (TTM)

ACXPN/A

FBLGN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

FBLG0.00x

Beta

ACXP-2.14

FBLG1.79

52W Performance

ACXP-84.3%

FBLG-88.8%

YTD Performance

ACXP-54.0%

FBLG-76.4%

% from 52W High

ACXP-84.4%

FBLG-89.0%

% from 52W Low

ACXP3.3%

FBLG82.3%

Asset Turnover (TTM)

ACXP0.00x

FBLG0.00x

FCF Yield (TTM)

ACXP-113.2%

FBLG-215.4%

Earnings Yield (TTM)

ACXP-137.5%

FBLG-264.0%

Dividend Yield (TTM)

ACXPN/A

FBLGN/A

Rule of 40

ACXP0.0

FBLG0.0

EV/GP/RG

ACXPN/A

FBLGN/A

Ticker research

View ACXP research View FBLG research

Metric	ACXP Acurx Pharmaceuticals Inc	FBLG Fibrobiologics Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$3M
Price	$1.27	$1.13
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	1.78x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	-0.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	227.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-18M
FCF (TTM)	$-6M	$-15M
EPS (TTM)	-$1.76	-$2.89
ROE (TTM)	-12474.0%	-53678.0%
ROA (TTM)	-8749.0%	-22512.0%
ROIC (TTM)	-12474.0%	-39304.0%
Financial Health
Cash	$11M	$4M
Debt	$0	$124K
Net Cash/Debt	$11M	$3M
Current Ratio (TTM)	3.88x	2.64x
Quick Ratio (TTM)	3.80x	2.40x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	1.79
52W Performance	-84.3%	-88.8%
YTD Performance	-54.0%	-76.4%
% from 52W High	-84.4%	-89.0%
% from 52W Low	3.3%	82.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-113.2%	-215.4%
Earnings Yield (TTM)	-137.5%	-264.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View FBLG research

Valuation

P/S Ratio

ACXP

0.00x

FBLG

0.00x

EV/FCF

FBLG

-0.24x

ACXP

0.84x

Growth & revenue

Forward Revenue Growth

FBLG

227.6%

ACXP

40.7%

Profitability & performance

Gross Margin

ACXP

0.0%

FBLG

0.0%

ROE

ACXP

-12474.0%

FBLG

-53678.0%

FCF Yield %

ACXP

-113.2%

FBLG

-215.4%

52-Week Performance

ACXP

-84.3%

FBLG

-88.8%

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

FBLG

Fibrobiologics Inc

Market Cap

ACXP$5M

FBLG$7M

Enterprise Value

ACXP$-5M

FBLG$3M

Price

ACXP$1.27

FBLG$1.13

P/E Ratio

ACXPN/A

FBLGN/A

P/S Ratio

ACXP0.00x

FBLG0.00x

EV/Sales

ACXP0.00x

FBLG0.00x

EV/EBITDA

ACXP0.00x

FBLG0.00x

P/B Ratio

ACXP0.87x

FBLG1.78x

P/FCF Ratio

ACXPN/A

FBLGN/A

EV/FCF

ACXP0.84x

FBLG-0.24x

PEG Ratio

ACXPN/A

FBLGN/A

Forward P/E (NTM)

ACXPN/A

FBLGN/A

Forward P/S (NTM)

ACXPN/A

FBLGN/A

Revenue (TTM)

ACXP$0

FBLG$0

Revenue Growth (YoY)

ACXPN/A

FBLGN/A

Forward Rev Growth

ACXP40.7%

FBLG227.6%

Gross Margin (TTM)

ACXP0.0%

FBLG0.0%

Operating Margin (TTM)

ACXP0.0%

FBLG0.0%

EBITDA Margin (TTM)

ACXP0.0%

FBLG0.0%

Net Margin (TTM)

ACXP0.0%

FBLG0.0%

FCF Margin (TTM)

ACXPN/A

FBLGN/A

Net Income (TTM)

ACXP$-8M

FBLG$-18M

FCF (TTM)

ACXP$-6M

FBLG$-15M

EPS (TTM)

ACXP-$1.76

FBLG-$2.89

ROE (TTM)

ACXP-12474.0%

FBLG-53678.0%

ROA (TTM)

ACXP-8749.0%

FBLG-22512.0%

ROIC (TTM)

ACXP-12474.0%

FBLG-39304.0%

Cash

ACXP$11M

FBLG$4M

Debt

ACXP$0

FBLG$124K

Net Cash/Debt

ACXP$11M

FBLG$3M

Current Ratio (TTM)

ACXP3.88x

FBLG2.64x

Quick Ratio (TTM)

ACXP3.80x

FBLG2.40x

Debt/Equity (TTM)

ACXP0.00x

FBLG0.03x

Debt/Assets (TTM)

ACXP0.0%

FBLG0.0%

Interest Coverage (TTM)

ACXPN/A

FBLGN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

FBLG0.00x

Beta

ACXP-2.14

FBLG1.79

52W Performance

ACXP-84.3%

FBLG-88.8%

YTD Performance

ACXP-54.0%

FBLG-76.4%

% from 52W High

ACXP-84.4%

FBLG-89.0%

% from 52W Low

ACXP3.3%

FBLG82.3%

Asset Turnover (TTM)

ACXP0.00x

FBLG0.00x

FCF Yield (TTM)

ACXP-113.2%

FBLG-215.4%

Earnings Yield (TTM)

ACXP-137.5%

FBLG-264.0%

Dividend Yield (TTM)

ACXPN/A

FBLGN/A

Rule of 40

ACXP0.0

FBLG0.0

EV/GP/RG

ACXPN/A

FBLGN/A

Ticker research

View ACXP research View FBLG research

Metric	ACXP Acurx Pharmaceuticals Inc	FBLG Fibrobiologics Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$3M
Price	$1.27	$1.13
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	1.78x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	-0.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	227.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-18M
FCF (TTM)	$-6M	$-15M
EPS (TTM)	-$1.76	-$2.89
ROE (TTM)	-12474.0%	-53678.0%
ROA (TTM)	-8749.0%	-22512.0%
ROIC (TTM)	-12474.0%	-39304.0%
Financial Health
Cash	$11M	$4M
Debt	$0	$124K
Net Cash/Debt	$11M	$3M
Current Ratio (TTM)	3.88x	2.64x
Quick Ratio (TTM)	3.80x	2.40x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	1.79
52W Performance	-84.3%	-88.8%
YTD Performance	-54.0%	-76.4%
% from 52W High	-84.4%	-89.0%
% from 52W Low	3.3%	82.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-113.2%	-215.4%
Earnings Yield (TTM)	-137.5%	-264.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View FBLG research